Abstract Spinal cord injury (SCI) often results in motor disability concomitant with limit neuroplasticity; the underlying mechanism, however, is still unclear. This study established spinal cord transection rats model (T10), then performed cDNA microarray analysis and found that vimentin located in astrocytes was increased significantly in scar tissues after transection. To understand the role of vimentin and it's mechanism of regulation, RNA interference and luciferase assay were used. Vimentin knockdown in the scar tissues showed a significant improvement on locomotor function in hindlimbs, while vimentin overexpression exhibited an opposite effect. In vitro, vimentin downregulation or overexpression can effectively inhibit or increase astrogliosis, respectively. Moreover, by using biological informatics technology, we predicted that vimentin may be as the target of micRNA138 (miR-138), and confirmed that miR-138 could regulate vimentin by luciferase activity assay. The present results not only validated the exact role of vimentin in transected spinal cord, but also exhibited a novel regulation mechanism, in which miR-138 may regulate vimentin to promote neuroplasticity. It, therefore, provides a novel target for gene drug discovery based on miRNA-138 or vimentin for the treatment of SCI in the future clinic trial.
Introduction
Spinal cord injury (SCI), resulted from mechanical damage or compression, could usually lead to motor, sensory, and sphincter dysfunction in the corresponding segments of the damage [1] . Following the primary injury, the secondary injury such as inflammatory response, hypoxia, and ion changes in microenvironment may provide optimal conditions for last glial scar formation, whereas the scar tissue may pave an obstacle for nerve regeneration and functional improvement [2] [3] [4] [5] .
It has been well known that astrocytes proliferated with hypertrophic can overexpress glial fibrillary acidic protein (GFAP) and vimentin to inhibit axonal regeneration [6, 7] . Therefore, there is a close relationship between GFAP and vimentin in reactive astrocytes. vimentin, as one of the most widely expressed mammalian intermediate filament proteins, is usually expressed in reactive astrocytes, and it was reported in mesenchyme cells, chondrocytes, and endothelial cells, particularly in fibroblast and differentiating cells. Studies have shown that the role of vimentin involves in cell adhesion, migration, survival, and signaling transduction via dynamic assembly/disassembly in cancer cells [8] . But the performance of vimentin in rats with spinal cord transection (SCT) and its regulating mechanism is still unclear.
microRNAs (miRNAs), as endogenous small non-coding RNA molecules (19) (20) (21) (22) bases in length), have been known to regulate protein coding gene expression by repressing translation or cleaving RNA transcripts in a sequence-specific manner [9] . The bulk of evidences reported that miRNAs take part in life activities, such as cancer development through the repression of tumor-associated gene [10] [11] [12] . However, it is not clear in injured spinal cord on the mechanism of miRNA for functional regulation.
In this study, we investigated the role of vimentin following SCT in rats and determined the possible molecular mechanism on miRNA regulation. The result could provide a novel strategy for the treatment of SCI in future clinic trial.
Materials and Methods

Animal and Grouping
The adult female Sprague-Dawley (SD) rats weighing 200± 20 g, supplied by the Animal Breeding Center of the Sichuan University, were used in this study. Animals raised on a comfortable and clean condition under a 12:12-h light/dark cycle, given plenty of food and water. All procedures were performed according to the Guide to the Care and Use of Experimental Animals published by the National Institute of Health (NIH publication 85-23, revised 1985) . Animal groups and experiment technology were shown as following (Table 1) .
SCT Model and Lentiviral Vectors Transfection
Before the operation, the rats were injected 3.6 % chloral hydrate (CCl 3 CH(OH) 2 ) (1 ml/kg) in intraperitoneal as anesthesia. After skin preparation, an incision about 1.5 cm in the level of thoracic 10 (T10) was prepared. Then, the spinal cord about 1 cm was exposed after vertebra arch was removed. Subsequently, ophthalmic scissors were used to cut the spinal cord completely. In order to determine the role of vimentin, the lentiviral vectors were injected into the spinal cord in two sites towards rostral direction and the other two sites towards caudal direction by stereotaxic equipment. Each point distance to incision to be performed was about 0.3 cm, and it was about 0.1 cm next to the middle line. The tip was inserted towards the incision with 30°angle in each site, and the depth into spinal cord was 1 cm. After injection, the needle was kept in the spinal cord for 1 min, so as to avoid virus to overflow. The volume of lentiviral vectors in each inject position was 5 μl. Lastly, the spinal cord was transected between two pair of injection sites. The wound was disinfected and closed.
Primary Astrocytes Culture and Lentiviral Transduction
Astrocytes were obtained from cerebral cortices of male neonatal Sprague-Dawley (SD) rats. The animals were decapitated, and the brains were fetched immediately and placed in phosphate buffered saline (PBS) at 4°C. After removing the meninges and blood vessels, the tissues were minced, washed and centrifuged, then incubated in 0.025 % (w/v) trypsin and 60 mg/ml DNase for 15-20 min. High-glucose Dulbecco's Modified Eagle Medium (DMEM) (Highclone, USA) containing 10 % (v/v) fetal bovine serum (FBS) was added to complete the trypsinization. Then cells (2∼5×10 5 /ml) were cultured in DMEM supplemented with 10 % FBS, 2 mM Lglutamine, 100 units/ml penicillin, and 100μg/ml streptomycin were maintained at 37°C with 5 % CO 2 . Cells were grown to confluence at which point they were placed on an orbital shaker for 6 h at 110 rpm. For neonatal astrocytes cultures, orbital shaking was used to remove oligodendrocytes and microglia [13] . After kept in the 24-well plates, medium was taken out and fresh medium was added. After this, the medium was changed every 3 days. At 6 days after culture, lentiviral recombinants were inoculated into medium to transfect astrocytes. At 2 days after transfection, five fields (200×) in each well were pictured, and the number of astrocytes was counted and compared.
BBB Test
The recovery of motor function in hindlimbs was observed, and BBB (Basso, Beattie, and Bresnahan open field locomotion rating score) [14] scoring system was used to evaluate the 
Microarray Analysis
To identify the potential target genes in scar after SCI, microarray analysis using Agilent rat whole genome (service provided by Kangchen Biotech, Shanghai, China) was performed to survey the gene expression of SCT group and sham as control. After hybridization and washing, the microarray slides were scanned with an Agilent DNA microarray scanner. The results were extracted from Agilent Feature Extraction Software (version 9.5.3), then imported into the Agilent GeneSpring GX software (version 7.3) for further analysis. Differentially, expressed genes were then identified through twofold change screening [15] .
Real-Time PCR
The primer sequences of PCR products were as follows: vimentin, sense 5′-TCAGACAGGATGTTGACAAT-3′ and antisense 5′-GACATGCTGTTCCTGAATCT-3′, TM CGTT CAAGGTCAAGACGTGCC. Total RNAwas extracted using TRIzol reagent (Invitrogen), and Real-Time PCR to quantify the gene level of vimentin was performed with conditions as follows: reverse transcription was done with the kit instruction (Denaturation at 95°C for 3 min; then amplification for 40 cycles at 95°C for 0.5 min, annealing at 50°C for 0.5 min, and extension at 60°C for 0.5 min; and then a terminal elongation step at 60°C for 10 min and a final holding stage at 4°C). β-actin served as an internal reference primer as 5′-GAAGATCAAGATCATTGCTCCT-3′, 5′-TACTCCTGCTTGCTGATCCA-3′, and TM CTGTCCAC CTTCCAGCAGA. 2 -△△CT method was employed to determine the relative expression of target genes.
Western Blotting
Tissue samples were lysed and homogenized in RIPA lysis buffer (Beyotime). Fifty milliliter buffer was added to one cocktail pill. A volume containing 100 μg of total protein was resolved in 15 % SDS-polyacrylamide gel, using the electrophoresis buffer (24.8 mM Tris; 192 mM glycine and 0.1 % SDS) at 60 V for 30 min, then 100 V for 1.5 h. After separated, the protein was transferred to PVDF membranes at 350 mA for 4 h, using the transfer buffer (24.8 mM Tris; 192 mM glycine; and 10 % methanol). This was followed by blocking with TBST, containing 5 % nonfat milk for 1 h at room temperature. Then the membranes were incubated with the rabbit anti-rat vimentin antibody (epitomics, 1:5,000) in TBS overnight at 4°C. After performed an incubation with the primary antibody, the membranes were repeatedly rinsed in TBST 4 times, and then incubated for 1.5 h in the secondary antibody (goat anti-rabbit IgG, 1:5,000, ZSGB-BIO, China). At last, the membranes were rinsed in TBST 4 times and developed in Alpha Innotech (BIO-RAD) with ECL. β-actin was internal control. The ratio of optic density for vimentin with β-actin was calculated to compare the difference.
Immunofluorescent Labeling
To determine the localization of vimentin, scar tissues and astrocytes were performed fluorescent staining. Briefly, sections and astrocytes were incubated in 5 % goat serum in PBS for 30 min at 37°C, then washed 3 times in PBS. After that, they were incubated in 2 % goat serum and 0.03 % Triton (Triton X-100, Sigma-Aldrich) in PBS, containing rabbit antirat vimentin antibody (epitomics, 1:200) for 18 h at 4°C, then rinsed with PBS. Continuously, section and astrocytes were incubated for 2 h at room temperature with the following secondary antibodies, goat anti-rabbit Cy3 (1:200, Jackson). This was followed by rinsed again with PBS, then incubated with DAPI (Beyotime Biotechnology) for 5 min. Finally, sections and astrocytes were observed under fluorescence microscopy.
Construction of vimentin Lentiviral ORF/SH-RNA Expression Plasmid
To explore the effect of vimentin on neuroplasticity after SCI, HIV (human immunodeficiency virus)-based vectors, the most popular and effective lentiviral-based expression systems at transducing genes into a wide variety of dividing and non-dividing mammalian cells were used both in vitro and in vivo. The plasmid, primers, and restriction enzymes were supplied by Gene Copoeia TM , China. The vimentin-SH target sequence was CCATCAACACCGAGTTCAA, whole plasmid size was 9,080 bp, reported gene was mcherryFP, cloning site at 5′ BamHI and 3′ EcoRI, hairpin loop sequence was TCAAGAG, RT-PCR primer forward 5′-CCCACAAC GAGGACTACA-3′, reverse 5′-CGTGAAGAATGTGCGA GAC-3′. The vimentin-ORF complementary DNA (cDNA) sequences were obtained by RT-PCR, using the following primers: forward 5′-GCGGTAGGCGTGTACGGT-3′, reverse 5′-CTGGAATAGCTCAGAGGC-3′. Lentiviral vectors of vimentin-ORF were suffered double enzyme digestion reaction, and then vimentin-ORF/SH lentiviral vectors were prepared and packaged in 293Ta cells. After prepared, lentiviral recombinant carrying vimentin-ORF/SHRNA were transfected into astrocytes and spinal cord, respectively, described before.
Bioinformatics Prediction
To predict miRNA that can regulate vimentin, TargetScan, Miranda, and PicTar software were used. The possible miRNA was chosen according to the combined site in gene sequence of 3′ UTR of vimentin.
Luciferase Reporter Assay
According to the result of prediction, we tested whether miRNA-138 could regulate vimentin by using luciferase assay. For luciferase reporter assays, PC12 cells were seeded in 96-well plates and co-transfected with 100 ng/ml of the 3′ UTR luci vector and 50 nM microRNA mimics or negative control. MicroRNA mimic and 3′ UTR vector were supplied by Ribobio, Guangzhou, China. 24 hours after transfection, luciferase activity was measured using the dual-luciferase reporter assay system kit (Promega) according to the manufacturer's instructions and a Tecan M 200 luminescence reader (Tecan Group Ltd, Männedorf, Switzerland). Values were double normalized to firefly luciferase activity and to cells transfected with empty was designated as control vectors.
Statistical Analysis
All data in the experiment are presented as mean ± SD. Comparisons between groups were analyzed with one-way ANOVA and independent samples t test using SPSS version 17.0. P<0.05 was considered to be statistically significant. *P<0.05, **P<0.01.
Result
BBB Scores and Differential Expression of vimentin in SCT Rats
BBB scores were recorded to evaluate the motor function in hindlimbs from SCT and sham rats. In sham group, BBB scores were 21, while rats after SCT movement on the hindlimbs disappeared (marked 0 score) in early stage, and it goes a gradual increase on BBB score, representing a limited recovery with time going (Fig. 1a) . Moreover, microarray technology was used to investigate the mechanism of hindlimbs movement disorder after SCI. Consequently, more than 2,800 genes exhibited differential expression. Of these, a family genes for intermediate filament (IF) were substantially (Fig. 1b) . As the most stable component of cytoskeleton, the IF family, finally, were chosen for further observation. According to the immunogenicity of tissue sources, we divided IF into five categories: keratin, desmin, glial fibrillary acidic protein, vimentin, and neurofilament protein. Importantly, two of IF, known as vimentin and keratin, were substantially upregulated, and vimentin was the most significant in scar following SCI, compared to sham one (Fig. 1c, Table 2 ).
Validation of vimentin by Real-Time-PCR and Immunofluorescence
In this study, Real-Time PCR was used to evaluate the transcriptional level of vimentin between the normal, sham, SCT14d, and SCT28d rats (Fig. 2a) . Lower expression of vimentin in normal and sham groups was observed. Attentively, a significant increase on vimentin expression in the scar in SCT14d (P=0) and SCT28d (P=0.002) groups was seen, respectively. Then, immunofluorescence was used to determine the localization of vimentin, which was showed in Fig. 2b, c, d , e, f, g, h, . e-g morphological field was 50×. Scale bar=20 μm, shown in j, and scale bar=80 μm in g i, j. In vitro, vimentin was expressed in cultured astrocytes (Fig. 2b, c, d ), whereas in vivo, few expression of vimentin could be found from longitudinal section of the normal spinal cord (Fig. 2e, f, g, h) . However, vimentin staining significantly increased in the scar at SCT14d (Fig. 2f) and SCT28d (Fig. 2g) . In 14 days after SCT, vimentin expression was found in astrocytes with round and uncleared boundary (Fig. 2i) ; while in 28 days after SCT, multiple processes morphology of astrocytes could be clearly seen, and the number of vimentin staining in astrocytes was still more than in sham one (Fig. 2j) .
Vimentin ORF/SH HIV Lentiviral Construction
HIV lentivirals were constructed to downregulate or overexpress vimentin in the scar. The structure of the plasmid of ORF/SH vimentin was shown on Fig. 3a, d . Whole plasmid of vimentin-ORF was 9,973 bp; the vector was Lv201 (Fig. 3a) ; ORF length was 1,401 bp; and the open reading frame sequence which was searched from NCBI (NM_031140) was showed in Fig. 3b . The plasmid of vimentin-ORF was packaged in 293Tα cells with emitting green fluorescence (Fig. 3e) . The result of the double enzyme digestion reaction was shown in Fig. 3c . Line 1 shows a strip indicated the plasmid of vimentin-ORF. Line 2 shows three strips, indicated the plasmid of vimentin-ORF digested by EcoRI and XhoI. The plasmid of vimentin-SH (NM_031140.1) target sequence was CCATCAACACCGAGTTCAA, whole plasmid size was 9,080 bp, reported gene was mcherryFP, cloning site at 5' BamHI and 3' EcoRI, and the hairpin loop sequence was TCAAGAG, as showed in Fig. 3d . The plasmid of vimentin-SH was packaged in 293Tα cells, and they could emit red fluorescence (Fig. 3f) The Role of Vimentin on Astrocytes Proliferation in Vitro 
Hindlimbs Motor Function Improvement Derived from Vimentin Administration in Vivo
After vimentin ORF/SH HIV lentiviral was injected into scar of spinal cord, western-blot and immunofluorescence were used to verify the expressional lever of vimentin in the scar (Fig. 5a, b) . Therefore, BBB scores can be responsible for motor functional recovery in hindlimbs following vimentin interference or overexpression (Fig. 5c) . Compared with the control group, the protein level of vimentin was higher in vimentin-ORF group (P=0.037), while BBB sores are lower than in control (P=0). On the contrary, in vimentin-SH group (P=0.019) for 28 days after injection, BBB scores exhibited a significant increase (P=0). These showed a significant motor function recovery in hindlimbs has occurred in vimentin-SH group (P=0) from 21 to 28 days after cord transection.
Test on Vimentin as a Target of miR-138 in PC12 System
Most miRNAs are thought to control gene expression by base-pairing with the miRNA-recognizing elements found in their messenger target. We utilized all three currently available major prediction programs, TargetScan, Miranda, and PicTar to analyze the potential interactions between miR-138 and vimentin. All these algorithms reveal that a potential miR-138 target site exists in the region of mRNA 3′ UTR for vimentin (Fig. 6) . To demonstrate the interaction between miR-138 and vimentin mRNA, we cloned vimentin 3′ UTR segment, which includes a potential target site for miR-138, and downstream of the pGL3 luciferase reporter gene was inserted, so as to generate the pGL3-vimentin vector. Then, luciferase activity in PC12 cells cotransfected with pGL3-vimentin vector was performed and tested. Consequently, miR-138 administration decreased markedly luciferase activity, compared with pGL3-vimentin vector and negative control (P = 0) (Fig. 6 ). These results confirmed the 3′ UTR of vimentin mRNA may be regulated by miR-138.
Discussion
In this study, first of all, a limited movement was found in rats after cord transection. This suggested that there is a weak repair capacity in the spinal cord following injury. However, this capacity does not meet the significant degree for effective movement. Formation of glial scar and inhibition of microenvironment (such as chondroitin sulphate proteoglycans and myelin-associated inhibitors), as well as the lack of sufficient neurotrophic support [16, 17] may be the main reason for dysfunction. Among these elements, reactive gliosis characterized with hypertrophy of astrocyte processes loading several intermediate filaments, including nestin, vimentin, and GFAP was known as the main obstacle for nerve regeneration. Using mice deficient to GFAP and vimentin, Pekny [18] demonstrated that the reactive astrocytes at an early stage after neurotrauma have a neuroprotective effect, while at a later stage, it seems to promote scar formation, so as to impede neurogenesis and axonal regeneration. Secondly, vimentin was highly expressed in scar after SCI at 14 and 28 days than in sham one. This suggested that vimentin is important for the scar formation. Many experiments have showed that there were large increases on vimentin positive cells in lesion site [19, 20] . In addition, vimentin was upregulated at four and a half days following a complete transection injury by cDNA microarray analysis in rats [21] . Moreover, our data confirmed the increase of vimentin could be lasted till 14 and 28 days via immunostaining. Together, vimentin may exert its role in inhibiting never regeneration within a long time after injury. Therefore, a knockdown of vimentin with long time in the spinal cord following SCT should be useful, to inhibit scar formation, and then permit nerve regeneration. In this study, we used lentiviral vector transfection technique to decrease the expression of vimentin. In order to know the sufficiency of transduction, the plasmid of vimentin-ORF/SH with green/red fluorescence was used. Simultaneously, we used Westernblot to detect the effectiveness of vimentin-ORF/SH. Consequently, immunofluorescent staining and western-blot showed vimentin in scar with astrocytes have successfully been upregulated or downregulated.
It has been well known that reactive astrocytes could as a barrier, inhibit nerve regeneration and neurite outgrowth [3] , while upregulation of intermediate filaments in reactive astrocytes is a key factor. Vimentin as one of IF, therefore, could be as a target to establish a novel repair strategy for the treatment of SCI. In this study, vimentin overexpression could promote the proliferation of astrocytes, while suppressed vimentin exhibited an inhibition for astrocytes. Importantly, vimentin knockdown results in a significant motor function recovery in hindlimbs. This provided a possible strategy based on vimentin suppression to treat SCI in the future. It is clear that vimentin could regulate glial cell proliferation. In vitro, survival of cortical neurons and neurite growth was improved in coculture with vimentin and GFAP double mutant mice [22, 23] . In vivo, this interaction was countered in adult mice after complete unilateral hemisection of the spinal cord [24] . As GFAP and vimentin are required for proper glial scar formation in the injured central nervous system, and to some degree, functional overlap may exist between these IF proteins and upregulation of astrocytic intermediate filaments [25] . It, therefore, needs to be determined for the role of vimentin in injured spinal cord again. Our study showed the vimentin suppression in astrocytes is important for last functional improvement, whereas react i v e a s t r o c y t e s w e r e a s p o t e n t i n h i b i t o r s f o r neuroregeneration [26] . Together, targeting towards vimentin may be a strategy for the treatment of SCI in the future.
Thirdly, by using biological informatics technology, we predicted that vimentin may be the target of miR-138 and confirmed that miR-138 could regulate vimentin by luciferase activity assay. miR-138 has been known to regulate a number Fig. 6 Validation on vimentin as a target of miR-138 in PC12. Luciferase activity assay reported an interaction between miR-138 and vimentin 3′ UTR site, and relative luciferase activity was shown in histogram of essential biological processes, including mammary glands development [27] , dendritic spine morphogenesis [28] , cardiac patterning modulating during embryonic stage [29] , and thermotolerance acquisition [30] . In tumor field, role of miR-138 has been largely addressed. The downregulation of miR-138 in thyroid cancer [31] , lung cancer [32] , leukemia [33] , and HNSCC cell lines showed a positive role to enhance cell migration and invasion [34, 35] . Moreover, several targets regulated by miR-138 have been reported. These should include enhancer of zeste homolog 2 (EZH2) and P16 in neck squamous cell carcinoma [36] ; 3-phosphoinositide-dependent protein kinase-1 (PDK1) in non-small cell lung cancer cells [37] ; S100A1 in hypoxia-induced endothelial cells [38] ; twist basic helix-loop-helix transcription factor 2 gene (TWIST2) in colorectal cancer [39] ; JNK and c-jun in hypoxia cardial myocytes [40] ; required for meiotic nuclear division 5 homolog A (RMND5A) in HeLa cells [41] ; serine/threonine kinase Mst1 in hypoxic pulmonary vascular remodeling [42] ; Ras homolog gene family, member C (RhoC) in cholangiocarcinoma [43] ; reelin in chicken embryonic hypothalamic cells [44] ; cyclin D1 (CCND1) in nasopharyngeal carcinoma [45] ; and cyclin D3 in hepatocellular carcinoma [46] . Recent evidence in nervous system has showed that miR-138 could regulate oligodendrocyte differentiation and myelin maintenance [47] . However, little report is designed to talk the role of miR-138 in injured spinal cord. In this study, we found that there was an interaction between miR-138 and 3′ UTR site of vimentin, indicated by luciferase activity assay. From our knowledge, this is the first time to report vimentin may be as a target of miR-138 in injured spinal cord.
In summary, this study found the expression of vimentin was upregulated within long time in scar following SCT. Vimentin overexpression or suppression could regulate the astrogliosis in vitro, and vimentin knockdown could give a fruitful consequence in promoting motor functional recovery in hindlimbs from SCT rats. In addition, we showed that vimentin could be regulated by miR-138, which indicated vimentin may be as a target of miR-138. These findings may give a novel indication, in which miR-138 or vimentin could be as a novel target for the treatment of SCI in future clinic practice.
